Harry Shapiro: What you see in drugs may not be what you get
Your support helps us to tell the story
From reproductive rights to climate change to Big Tech, The Independent is on the ground when the story is developing. Whether it's investigating the financials of Elon Musk's pro-Trump PAC or producing our latest documentary, 'The A Word', which shines a light on the American women fighting for reproductive rights, we know how important it is to parse out the facts from the messaging.
At such a critical moment in US history, we need reporters on the ground. Your donation allows us to keep sending journalists to speak to both sides of the story.
The Independent is trusted by Americans across the entire political spectrum. And unlike many other quality news outlets, we choose not to lock Americans out of our reporting and analysis with paywalls. We believe quality journalism should be available to everyone, paid for by those who can afford it.
Your support makes all the difference.The emergence of so-called "legal highs" means another layer has been added to the existing market in psychoactive substances. While the Government might control various legal highs through legislation, in terms of public health and safety advice, these drugs are not more "reliable" or safe than more familiar drugs like cocaine or ecstasy.
Users might buy the same packet containing a substance that looks the same as one they bought previously from a website or headshop, but the drugs might be different – with different potency or effects. There is no more "quality control" in the legal highs market than if you were buying heroin or cocaine.
A lot of the substances known as legal highs have already been controlled. The Government has brought mephedrone (known as miaow miaow) and synthetic cannabinoids such as Spice under the Misuse of Drugs Act.
One issue is the speed at which new substances become available and how long they sit outside the legal framework. The Government, drug agencies and health professionals are sometimes playing catch up. From an enforcement point of view, this is a major challenge, particularly if the drugs are bought online.
Small scale home production of most of these substances is unlikely. There may be a move from traditional producer countries for illegal drugs, like Peru, Afghanistan and Colombia, into China and eastern Europe, which have many chemical factories and large pharmaceutical markets. We are starting to see new outlets for production.
It's partly a damage limitation exercise, but drugs often go in cycles, based on availability and price. In the 1980s, glue sniffing was more common and ecstasy was a major drug trend in the UK. It is hard to pin down why cycles change. Legal highs are a phenomenon of the last few years, while other drug scenes go back 10 to 20 years, or more.
It is difficult to predict what the impacts will be, but at the very least, we are adding a new and significant dimension to the world drugs situation.
The writer is director of communications for DrugScope
Join our commenting forum
Join thought-provoking conversations, follow other Independent readers and see their replies
Comments